Leila M. Boustany

1.2k total citations
12 papers, 824 citations indexed

About

Leila M. Boustany is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Leila M. Boustany has authored 12 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Leila M. Boustany's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Pain Mechanisms and Treatments (3 papers) and Food Allergy and Anaphylaxis Research (2 papers). Leila M. Boustany is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Pain Mechanisms and Treatments (3 papers) and Food Allergy and Anaphylaxis Research (2 papers). Leila M. Boustany collaborates with scholars based in United States, France and Israel. Leila M. Boustany's co-authors include Martha Cyert, Theodore H. Lindsay, Kazufumi Kubota, Molly A. Sevcik, Patrick W. Mantyh, Joseph R. Ghilardi, David L. Shelton, Kyle G. Halvorson, Liang Hong and Michael A. Kuskowski and has published in prestigious journals such as Journal of Biological Chemistry, Genes & Development and Cancer Research.

In The Last Decade

Leila M. Boustany

11 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leila M. Boustany United States 8 350 271 174 169 164 12 824
Zhan Shi China 14 100 0.3× 175 0.6× 41 0.2× 120 0.7× 40 0.2× 24 663
Tiffany Lam United States 7 130 0.4× 190 0.7× 30 0.2× 181 1.1× 107 0.7× 16 699
Maelig Morvan United States 9 257 0.7× 286 1.1× 27 0.2× 508 3.0× 148 0.9× 10 1.4k
Kay McNamee United Kingdom 13 146 0.4× 171 0.6× 53 0.3× 124 0.7× 53 0.3× 14 909
Rehman Qureshi United States 10 119 0.3× 358 1.3× 15 0.1× 59 0.3× 52 0.3× 21 627
Emma L. Braine Australia 14 114 0.3× 297 1.1× 42 0.2× 101 0.6× 248 1.5× 24 996
Daying Zhang China 14 123 0.4× 83 0.3× 29 0.2× 39 0.2× 43 0.3× 31 417
Pamela G. Galloway United States 14 401 1.1× 349 1.3× 24 0.1× 101 0.6× 189 1.2× 29 1.0k
Richard Kirkland United States 7 173 0.5× 175 0.6× 63 0.4× 75 0.4× 27 0.2× 16 640
Akiko Kamiyoshi Japan 18 91 0.3× 518 1.9× 30 0.2× 118 0.7× 372 2.3× 47 959

Countries citing papers authored by Leila M. Boustany

Since Specialization
Citations

This map shows the geographic impact of Leila M. Boustany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leila M. Boustany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leila M. Boustany more than expected).

Fields of papers citing papers by Leila M. Boustany

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leila M. Boustany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leila M. Boustany. The network helps show where Leila M. Boustany may publish in the future.

Co-authorship network of co-authors of Leila M. Boustany

This figure shows the co-authorship network connecting the top 25 collaborators of Leila M. Boustany. A scholar is included among the top collaborators of Leila M. Boustany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leila M. Boustany. Leila M. Boustany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Boustany, Leila M., et al.. (2023). Anaphylaxies à la banane chez l’adulte et l’enfant, les données du Réseau d’allergo-vigilance® depuis 2002 – Revue générale. Revue française d'allergologie. 63(5). 103655–103655.
2.
Boustany, Leila M., Sherry L. LaPorte, Joel Shen, et al.. (2022). A Probody T Cell–Engaging Bispecific Antibody Targeting EGFR and CD3 Inhibits Colon Cancer Growth with Limited Toxicity. Cancer Research. 82(22). 4288–4298. 35 indexed citations
3.
Berezhnoy, Alexey, Hsin Wang, Na Cai, et al.. (2022). 1078 Conditionally activatable interferon-alpha 2b improves tolerability and exhibits preferential activity in tumors. Regular and Young Investigator Award Abstracts. A1120–A1120. 1 indexed citations
4.
Berezhnoy, Alexey, Hsin Wang, Michael B. Winter, et al.. (2022). Abstract 2071: Probody-interferon-alpha 2b combines antitumor activity with improved tolerability. Cancer Research. 82(12_Supplement). 2071–2071. 1 indexed citations
5.
Sabouraud-Leclerc, D., et al.. (2022). Anaphylaxies aux PR10 chez l’enfant, les données du Réseau d’Allergo-Vigilance® depuis 2002. Revue française d'allergologie. 62(2). 148–153. 5 indexed citations
6.
Boustany, Leila M., Linnea Diep, Yuanhui Huang, et al.. (2018). Abstract A164: EGFR-CD3 bispecific Probody™ therapeutic induces tumor regressions and increases maximum tolerated dose >60-fold in preclinical studies. Molecular Cancer Therapeutics. 17(1_Supplement). A164–A164. 25 indexed citations
7.
Abdiche, Yasmina, Xiaodi Deng, Yik A. Yeung, et al.. (2015). Assessing kinetic and epitopic diversity across orthogonal monoclonal antibody generation platforms. mAbs. 8(2). 264–277. 39 indexed citations
8.
Chaparro‐Riggers, Javier, Liang Hong, Rachel M. DeVay, et al.. (2012). Increasing Serum Half-life and Extending Cholesterol Lowering in Vivo by Engineering Antibody with pH-sensitive Binding to PCSK9. Journal of Biological Chemistry. 287(14). 11090–11097. 137 indexed citations
9.
Wu, Chaoran, Leila M. Boustany, Liang Hong, & Timothy J. Brennan. (2007). Nerve Growth Factor Expression after Plantar Incision in the Rat. Anesthesiology. 107(1). 128–135. 72 indexed citations
10.
Sevcik, Molly A., Joseph R. Ghilardi, Christopher M. Peters, et al.. (2005). Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization. Pain. 115(1). 128–141. 239 indexed citations
11.
Halvorson, Kyle G., Kazufumi Kubota, Molly A. Sevcik, et al.. (2005). A Blocking Antibody to Nerve Growth Factor Attenuates Skeletal Pain Induced by Prostate Tumor Cells Growing in Bone. Cancer Research. 65(20). 9426–9435. 166 indexed citations
12.
Boustany, Leila M. & Martha Cyert. (2002). Calcineurin-dependent regulation of Crz1p nuclear export requires Msn5p and a conserved calcineurin docking site. Genes & Development. 16(5). 608–619. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhan Shi Breakdown of academic impact, for papers by Tiffany Lam Breakdown of academic impact, for papers by Maelig Morvan Breakdown of academic impact, for papers by Kay McNamee Breakdown of academic impact, for papers by Rehman Qureshi Breakdown of academic impact, for papers by Emma L. Braine Breakdown of academic impact, for papers by Daying Zhang Breakdown of academic impact, for papers by Pamela G. Galloway Breakdown of academic impact, for papers by Richard Kirkland Breakdown of academic impact, for papers by Akiko Kamiyoshi
Rankless by CCL
2026